Fig. 1.From: The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer48-year-old man presents with PSA 11.30 ng/mL and PSA density 0.31 ng/mL2 for targeted prostate biopsy: mpMRI A shows a PI-RADS 4 lesion in the right lateral base whereas 68 Ga-PSMA11 axial PET B, axial fused PET/MRI C, and maximum intensity projection (MIP) D reveal a larger tumor volume. Subsequent PET-targeted biopsy resulted in a Gleason score 4 + 3 prostate cancerBack to article page